Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause

T E J Theunissen; M Nguyen; R Kamps; AT Hendrickx; S Sallevelt; RWH Gottschalk; CM Calis; APM Stassen; BAE Koning; E N M Mulder-Den Hartog; Kees Schoonderwoerd; SA Fuchs; Y Hilhorst-Hofstee; M Visser; J Vanoevelen; R Szklarczyk; M Gerards; IFM de Coo; D Hellebrekers; HJM Smeets

doi:10.3389/fgene.2018.00400

Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause

T E J Theunissen, M Nguyen, R Kamps, AT Hendrickx, S Sallevelt, RWH Gottschalk, CM Calis, APM Stassen, BAE Koning, E N M Mulder-Den Hartog, Kees Schoonderwoerd, SA Fuchs, Y Hilhorst-Hofstee, M Visser, J Vanoevelen, R Szklarczyk, M Gerards, IFM de Coo, D Hellebrekers, HJM Smeets

Clinical Genetics

Research output: Contribution to journal › Article › Academic › peer-review

67 Citations (Scopus)

23 Downloads (Pure)

Original language	Undefined/Unknown
Article number	400
Journal	Frontiers in Genetics
Volume	9
DOIs	https://doi.org/10.3389/fgene.2018.00400
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.3389/fgene.2018.00400

Repub_111516_O-A.pdfFinal published version, 759 KB

http://hdl.handle.net/1765/111516

Cite this

Theunissen, T. E. J., Nguyen, M., Kamps, R., Hendrickx, AT., Sallevelt, S., Gottschalk, RWH., Calis, CM., Stassen, APM., Koning, BAE., Mulder-Den Hartog, E. N. M., Schoonderwoerd, K., Fuchs, SA., Hilhorst-Hofstee, Y., Visser, M., Vanoevelen, J., Szklarczyk, R., Gerards, M., de Coo, IFM., Hellebrekers, D., & Smeets, HJM. (2018). Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause. Frontiers in Genetics, 9, Article 400. https://doi.org/10.3389/fgene.2018.00400

@article{83cbf628fc284f1eab131ee06def11f2,

title = "Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause",

author = "Theunissen, {T E J} and M Nguyen and R Kamps and AT Hendrickx and S Sallevelt and RWH Gottschalk and CM Calis and APM Stassen and BAE Koning and {Mulder-Den Hartog}, {E N M} and Kees Schoonderwoerd and SA Fuchs and Y Hilhorst-Hofstee and M Visser and J Vanoevelen and R Szklarczyk and M Gerards and {de Coo}, IFM and D Hellebrekers and HJM Smeets",

year = "2018",

doi = "10.3389/fgene.2018.00400",

language = "Undefined/Unknown",

volume = "9",

journal = "Frontiers in Genetics",

issn = "1664-8021",

publisher = "Frontiers Media S.A.",

}

Theunissen, TEJ, Nguyen, M, Kamps, R, Hendrickx, AT, Sallevelt, S, Gottschalk, RWH, Calis, CM, Stassen, APM, Koning, BAE, Mulder-Den Hartog, ENM, Schoonderwoerd, K, Fuchs, SA, Hilhorst-Hofstee, Y, Visser, M, Vanoevelen, J, Szklarczyk, R, Gerards, M, de Coo, IFM, Hellebrekers, D & Smeets, HJM 2018, 'Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause', Frontiers in Genetics, vol. 9, 400. https://doi.org/10.3389/fgene.2018.00400

TY - JOUR

T1 - Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause

AU - Theunissen, T E J

AU - Nguyen, M

AU - Kamps, R

AU - Hendrickx, AT

AU - Sallevelt, S

AU - Gottschalk, RWH

AU - Calis, CM

AU - Stassen, APM

AU - Koning, BAE

AU - Mulder-Den Hartog, E N M

AU - Schoonderwoerd, Kees

AU - Fuchs, SA

AU - Hilhorst-Hofstee, Y

AU - Visser, M

AU - Vanoevelen, J

AU - Szklarczyk, R

AU - Gerards, M

AU - de Coo, IFM

AU - Hellebrekers, D

AU - Smeets, HJM

PY - 2018

Y1 - 2018

U2 - 10.3389/fgene.2018.00400

DO - 10.3389/fgene.2018.00400

M3 - Article

C2 - 30369941

SN - 1664-8021

VL - 9

JO - Frontiers in Genetics

JF - Frontiers in Genetics

M1 - 400

ER -